Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Tinnitus

etoposide has been researched along with Tinnitus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daoud, J; Elloumi, F; Fourati, N; Frikha, M; Ghorbel, A; Ghorbell, L; Jlidi, R; Siala, W1
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T1
Abu Zaid, M; Althouse, S; Ardeshir-Rouhani-Fard, S; Beard, CJ; Cook, R; Einhorn, LH; Feldman, DR; Fossa, SD; Fung, C; Hamilton, RJ; Kerns, SL; Kollmannsberger, CK; Lipshultz, SE; Monahan, P; Sesso, HD; Travis, LB; Vaughn, DJ; Williams, AM1
Anderson, D; Leonetti, JP; Marzo, S; Shirazi, MA1

Other Studies

4 other study(ies) available for etoposide and Tinnitus

ArticleYear
[Large cell neuroendocrine carcinoma of the nasopharynx: A case report].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3

    Topics: Adult; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Nasal Obstruction; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tinnitus

2014
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Urologic oncology, 2016, Volume: 34, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Carboplatin; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Comorbidity; Etoposide; Follow-Up Studies; Hearing Loss; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Norway; Orchiectomy; Peripheral Nervous System Diseases; Surveys and Questionnaires; Testicular Neoplasms; Tinnitus; Vinblastine; Young Adult

2016
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-10, Volume: 35, Issue:11

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Case-Control Studies; Cisplatin; Etoposide; Exercise; Health Status; Hearing Loss; Humans; Long Term Adverse Effects; Male; Middle Aged; Obesity; Peripheral Nervous System Diseases; Prevalence; Protective Factors; Raynaud Disease; Risk Factors; Smoking; Surveys and Questionnaires; Survivors; Testicular Neoplasms; Tinnitus; United States; Young Adult

2017
Neuroendocrine carcinoma of the jugular foramen.
    Ear, nose, & throat journal, 2008, Volume: 87, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Female; Headache; Hearing Loss, Sensorineural; Humans; Jugular Veins; Magnetic Resonance Imaging; Middle Aged; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Skull Base Neoplasms; Tinnitus; Vertigo

2008